Findings of Threefold Increased Risk Contradict Most Previous Research
Sept. 13, 2004 --The hepatitis B vaccine series has been administered to more than 20 million people in the US and more than 500 million people in the world …
Now a new study in the Sept. 14 issue of the journal Neurology offers some of the strongest evidence supporting the link.
In the study, researchers report that vaccination with the recombinant hepatitis B vaccine is associated with a threefold increased risk of multiple sclerosis ...
full story available at: http://aolsvc.health.webmd.aol.com/content/article/94/102604
No comments:
Post a Comment